Topics: Value-Driven Health Care, GoBoldly, The Value Collaborative
From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.
lg_1000x775_value-collaborative-no-tag.
Following the biopharmaceutical industry’s recent meeting with President Donald J. Trump, PhRMA president and CEO Stephen J. Ubl joined Dan Diamond on POLITICO’s Pulse Check podcast to discuss the future of innovation in health care and the industry’s new national advertising and public affairs campaign: GOBOLDLY™. The campaign focuses on the new era of medicine, public health and ways we can evolve our private payment and reimbursement system to be as innovative as the medicines our companies produce.
Listen to the full interview here, and visit GoBoldly.com and Innovation.org to learn more about #GOBOLDLY.
Topics: Value-Driven Health Care, GoBoldly, The Value Collaborative
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."